M Saito-Yabe

Summary

Affiliation: Daiichi Sankyo Co
Country: Japan

Publications

  1. ncbi Highly frequent anti-idiotype antibody in cynomolgus monkeys developed against mouse-derived regions of anti-Fas antibody humanized by complementarity determining region grafting
    M Saito-Yabe
    Drug Metabolism and Pharmacokinetics Research Laboratories, Daiichi Sankyo Co, Ltd, Shinagawa ku, Tokyo, Japan
    Br J Pharmacol 158:548-57. 2009
  2. ncbi PEGylation of osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF) results in decreased uptake into rats and human liver
    Motoko Saito-Yabe
    Drug Metabolism and Pharmacokinetics Research Laboratories, Daiichi Sankyo Co, Ltd, Tokyo, Japan
    J Pharm Pharmacol 62:985-94. 2010

Detail Information

Publications2

  1. ncbi Highly frequent anti-idiotype antibody in cynomolgus monkeys developed against mouse-derived regions of anti-Fas antibody humanized by complementarity determining region grafting
    M Saito-Yabe
    Drug Metabolism and Pharmacokinetics Research Laboratories, Daiichi Sankyo Co, Ltd, Shinagawa ku, Tokyo, Japan
    Br J Pharmacol 158:548-57. 2009
    ..We investigated the immunogenicity of a humanized anti-human Fas monoclonal antibody, R-125224, in cynomolgus monkeys to estimate its efficacy, as well as its toxicity in clinical situations...
  2. ncbi PEGylation of osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF) results in decreased uptake into rats and human liver
    Motoko Saito-Yabe
    Drug Metabolism and Pharmacokinetics Research Laboratories, Daiichi Sankyo Co, Ltd, Tokyo, Japan
    J Pharm Pharmacol 62:985-94. 2010
    ..Our aim was to investigate the effect of PEGylation on the uptake of osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF) into rat liver, kidney and spleen, and human liver...